Advertisement
Canada markets close in 5 hours 36 minutes

  • S&P/TSX

    21,722.19
    -151.53 (-0.69%)
     

  • S&P 500

    5,010.73
    -60.90 (-1.20%)
     

  • DOW

    37,830.04
    -630.88 (-1.64%)
     

  • CAD/USD

    0.7294
    -0.0003 (-0.05%)
     

  • CRUDE OIL

    82.44
    -0.37 (-0.45%)
     

  • Bitcoin CAD

    87,365.21
    -3,006.02 (-3.33%)
     

  • CMC Crypto 200

    1,374.48
    -8.09 (-0.59%)
     

  • GOLD FUTURES

    2,333.20
    -5.20 (-0.22%)
     

  • RUSSELL 2000

    1,961.45
    -33.98 (-1.70%)
     

  • 10-Yr Bond

    4.7270
    +0.0750 (+1.61%)
     

  • NASDAQ

    15,493.67
    -219.07 (-1.39%)
     

  • VOLATILITY

    17.35
    +1.38 (+8.63%)
     

  • FTSE

    8,051.49
    +11.11 (+0.14%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6806
    -0.0013 (-0.19%)
     
BREAKING:

HONDA TO SET UP $15B EV PRODUCTION BASE IN CANADA

Automaker to get up to $5B in government assistance for EV battery, assembly plants

Stocks in play: Tryp Therapeutics Inc

Baystreet.ca

Announced today that it has received confirmation from the U.S. Food and Drug Administration that its review of Tryp's Investigational New Drug application is complete and that the Company may proceed with its clinical study in fibromyalgia. Tryp is a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs. Tryp Therapeutics Inc shares C.TRYP are trading up 0.01 cent at $0.23.

Read: